Study of Lisaftoclax (APG-2575) Single Agent and Combination With Therapy in Patients Relapsed/Refractory AML
Clinical trial NCT04501120 · RECRUITING
Trial details
- NCT number
- NCT04501120
- Sponsor
- Ascentage Pharma Group Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-28
- Primary completion
- 2028-09-01
- Enrollment
- 682
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.